Claim records

2 shown · bounded preview

RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA

CLAIM · CLM-cb63024fca200a6bGRADE VERY_LOW

noni constituents — inflammation

direction BENEFIT · dose 8 mg/kg · duration 10 weeks

Grade basis — weakest-link ceilings

VERY_LOWdesign

LOWdirectness

LOWextraction

VERY_LOWconfidence

MODERATEmethodology

MODERATEconsistency

MODERATEnumeric

7bound studies

Bound studies (4 shown of 7)

STU-04dc8a0390917adb

IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION

3 endpoints

STU-11397198053bed12

ANIMAL · ANIMAL · 2022 · 10 weeks · RoB INSUFFICIENT_INFORMATION

7 endpoints

STU-1ba26728102f7c9e

ANIMAL · ANIMAL · 2009 · RoB INSUFFICIENT_INFORMATION

1 endpoints

STU-1bc07b9005ffbd95

ANIMAL · ANIMAL · 2023 · 10 weeks · RoB INSUFFICIENT_INFORMATION

7 endpoints

Quantitative observations

observation 8 mg/kg · validated

observation reduction by 45% · unvalidated

observation p < 0.05 · validated

Opposition screen

SCREEN · 15 candidates considered · 3 bound as opposing

SYNTHESIS SYN-7137c75d7c3173 — outcome QUALITATIVE_ONLY · BENEFIT ×7 · not_assessed_quantitatively · 7 members

PROVENANCE → epmc:IND609230963, epmc:36076420, crf:10.1002/ptr.2863 · PKG 874aff9d46fc8848…

CLAIM · CLM-e39b406d3943a65eGRADE VERY_LOW

noni constituents — antioxidant

direction BENEFIT · dose 8 mg/kg · duration 10 weeks

Grade basis — weakest-link ceilings

VERY_LOWdesign

LOWdirectness

MODERATEextraction

LOWconfidence

MODERATEmethodology

MODERATEconsistency

MODERATEnumeric

7bound studies

Bound studies (4 shown of 7)

STU-04dc8a0390917adb

IN_VITRO · IN_VITRO · 2025 · RoB INSUFFICIENT_INFORMATION

3 endpoints

STU-11397198053bed12

ANIMAL · ANIMAL · 2022 · 10 weeks · RoB INSUFFICIENT_INFORMATION

7 endpoints

STU-1bc07b9005ffbd95

ANIMAL · ANIMAL · 2023 · 10 weeks · RoB INSUFFICIENT_INFORMATION

7 endpoints

STU-71af535878314710

ANIMAL · ANIMAL · 2022 · RoB INSUFFICIENT_INFORMATION

3 endpoints

Quantitative observations

observation 8 mg/kg · validated

observation reduction by 45% · unvalidated

observation p < 0.05 · validated

Opposition screen

SCREEN · 13 candidates considered · 2 bound as opposing

SYNTHESIS SYN-6ae8a42fd2fb90 — outcome QUALITATIVE_ONLY · BENEFIT ×7 · not_assessed_quantitatively · 7 members

PROVENANCE → epmc:IND609230963, epmc:36076420, epmc:IND607838444 · PKG 874aff9d46fc8848…

Bounded preview — representative records only. The full release ships 30 claims and 82 observations.

Noni.

Claim records